1.
Blood
; 140:5027-5028, 2022.
Article
in English
| ScienceDirect | ID: covidwho-2120100
2.
Br J Haematol
; 199(4): e21-e24, 2022 11.
Article
in English
| MEDLINE | ID: covidwho-2019155
3.
J Clin Apher
; 35(4): 378-381, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-633842
ABSTRACT
As the COVID-19 pandemic continues to claim lives across the globe, insufficient data exists regarding the optimal treatment. It is well known that patients 55 years of age or older and patients with certain chronic diseases are at higher risk of severe illness, including acute respiratory distress syndrome and death. A potentially fatal pulmonary complication of sickle cell disease, acute chest syndrome, can be precipitated by acute infections, including respiratory viruses. We report the case of a patient with sickle cell disease (HbSC) who developed COVID-19 pneumonia and acute chest syndrome who was treated with emergent red blood cell exchange in order to avoid endotracheal intubation.
Subject(s)
Anemia, Sickle Cell/complications , Betacoronavirus , Coronavirus Infections/complications , Erythrocyte Transfusion/methods , Intubation, Intratracheal , Pandemics , Pneumonia, Viral/complications , Respiratory Insufficiency/therapy , Acute Chest Syndrome/etiology , Acute Chest Syndrome/therapy , Adult , Analgesics/therapeutic use , Antiviral Agents/therapeutic use , Azithromycin/therapeutic use , COVID-19 , Combined Modality Therapy , Contraindications, Procedure , Coronavirus Infections/drug therapy , Humans , Hydroxychloroquine/therapeutic use , Male , Methylprednisolone/therapeutic use , Oxygen Inhalation Therapy , Pneumonia, Viral/drug therapy , Respiration, Artificial , Respiratory Insufficiency/etiology , SARS-CoV-2
4.
Br J Haematol
; 189(5): 851-852, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-100639